Xylem (NYSE: XYL) reported Q3 EPS of $0.53, $0.01 better than the analyst estimate of $0.52. Revenue for the quarter came in at $963 million versus the consensus estimate of $982.1 million.

Xylem sees FY2014 EPS of $1.92-$1.98.

For earnings history and earnings-related data on Xylem (XYL) click here.